Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Cosmetic Surgery Products Market size was valued at USD 20.49 billion in 2024 and is expected to reach USD 57.08 billion by 2037, registering around 8.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cosmetic surgery products is evaluated at USD 21.92 billion.
The growth of the market can be attributed to factors such as rising beauty consciousness among people, increasing adoption of invasive and minimally invasive surgeries to remain youthful, and improvement in cosmetic treatment procedures. In addition to these, rapidly ageing population around the world and growing disposable income of the people are also projected to drive market growth in the near future. According to the World Health Organization (WHO), the number of people aged 60 years and above was 1 billion. This number is evaluated to increase up to 1,4 billion by the end of 2030. Furthermore, glossy advertisements by entertainment industry to attract more and more people to their services is expected to offer lucrative opportunities to the market in the upcoming years.
Cosmetic Surgery Products Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Beauty Consciousness of People Worldwide
- Rapid Improvement in Cosmetic Surgery Procedures
Challenges
- High Cost of Aesthetic Treatments
Cosmetic Surgery Products Market: Key Insights
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
8.2% |
|
Base Year Market Size (2023) |
USD 18.94 billion |
|
Forecast Year Market Size (2036) |
USD 52.76 billion |
|
Regional Scope |
|
Cosmetic Surgery Products Segmentation
The market is segmented by product type into implants, injectables, and equipment, out of which, the injectables segment is anticipated to witness the highest growth in the cosmetic surgery products market on account of wide usage of treatments such as BOTOX and dermal fillers for adding volume to the skin to erase lines and wrinkles near the chin, forehead and nose. Among all different types of non-surgical procedures undergone, botulin toxin (BOTOX) accounted for the largest share in 2018. The calculated value was approximately 7.5 million procedures. On the basis of procedure, the segment for non-surgical procedure is assessed to occupy the largest market share during the forecast period, which can be credited to the increasing demand for these procedures since the last few years owing to the benefits such as shorter recovery time, minimal or no pain, lower cost and reduced risk of side-effects.
Our in-depth analysis of the global market includes the following segments
|
By Product Type |
|
|
By Procedure |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportCosmetic Surgery Products Industry - Regional Synopsis
North America Market Statistics
On the basis of geographical analysis, the cosmetic surgery products market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is likely to dominate majority revenue share by 2037, on the back of growing adoption of sophisticated surgical techniques and a high number of successful cosmetics surgeries in the region.
APAC Market Analysis
Moreover, Asia Pacific is anticipated to witness noteworthy market growth during the forecast period, which can be ascribed to the easier availability of cosmetic services at affordable rates, growing purchasing power of middle-class population and increasing disposable income of the people in the region.
Companies Dominating the Cosmetic Surgery Products Landscape
- Allergan PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sinclair Pharma Plc
- Cutera Inc
- Mentor Corporation
- Candela Corp
- Lumenis Ltd.
- Iridex Corp
- Johnson & Johnson Services, Inc.
- Syneron Medical Ltd.
- Cynosure Inc.
In the News
- July, 2019: Cynosure expanded its portfolio by launching two innovative aesthetic treatments, TempSure and SculpSure.
- March, 2019: Sinclair Pharma launched a minimally invasive treatment named SILHOUTTE SOFT which is designed to give a refreshed appearance through slight elevation and repositioning of the skin’s sagging tissue.
Author Credits: Radhika Pawar
- Report ID: 44
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
